Your browser doesn't support javascript.
The COVID-19 Pandemic and Coronary Angiography for ST-Elevation Myocardial Infarction, Use of Mechanical Support, and Mechanical Complications in Canada: A Canadian Association of Interventional Cardiology National Survey.
Rinfret, Stéphane; Jahan, Israth; McKenzie, Kevin; Dendukuri, Nandini; Bainey, Kevin R; Mansour, Samer; Natarajan, Madhu; Ybarra, Luiz F; Chong, Aun-Yeong; Bérubé, Simon; Breton, Robert; Curtis, Michael J; Rodés-Cabau, Josep; Shy Shoaib, Amlani; Bagherli, Alireza; Ball, Warren; Barolet, Alan; Beydoun, Hussein K; Brass, Neil; Chan, Albert W; Colizza, Franco; Constance, Christian; Fam, Neil P; Gobeil, François; Haghighat, Tinouch; Hodge, Steven; Joyal, Dominique; Kim, Hahn Hoe; Lutchmedial, Sohrab; MacDougall, Andrea; Malik, Paul; Miner, Steve; Minhas, Kunal; Orvold, Jason; Palisaitis, Donald; Parfrey, Brendan; Potvin, Jean-Michel; Puley, Geoffrey; Radhakrishnan, Sam; Spaziano, Marco; Tanguay, Jean-François; Vijayaraghaban, Ram; Webb, John G; Zimmermann, Rodney H; Wood, David A; Brophy, James M.
  • Rinfret S; Division of Cardiology, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
  • Jahan I; Department of Medicine and Biostatistics, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
  • McKenzie K; Canadian Association of Interventional Cardiology, Ottawa, Ontario, Canada.
  • Dendukuri N; Department of Medicine and Biostatistics, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
  • Bainey KR; Division of Cardiology, Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada.
  • Mansour S; Division of Cardiology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
  • Natarajan M; Division of Cardiology, Hôpital de la Cité-de-la-Santé, Laval, Quebec, Canada.
  • Ybarra LF; Division of Cardiology, Hamilton Health Sciences Centre, Hamilton, Ontario, Canada.
  • Chong AY; Division of Cardiology, London Health Sciences Centre, London, Ontario, Canada.
  • Bérubé S; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • Breton R; Division of Cardiology, CIUSSS de l'Estrie-CHUS, Sherbrooke, Quebec, Canada.
  • Curtis MJ; Division of Cardiology, CIUSSS Saguenay Lac Saint Jean, Saguenay, Quebec, Canada.
  • Rodés-Cabau J; Division of Cardiology, Foothills Medical Centre, Calgary, Alberta, Canada.
  • Shy Shoaib A; Multidisciplinary Department of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec-Hôpital Laval, Quebec City, Quebec, Canada.
  • Bagherli A; Division of Cardiology, William Osler Health System, Brampton, Ontario, Canada.
  • Ball W; Division of Cardiology, Windsor Regional Hospital, Windsor, Ontario, Canada.
  • Barolet A; Division of Cardiology, Peterborough Regional Health Centre, Peterborough, Ontario, Canada.
  • Beydoun HK; Division of Cardiology, University Health Network-Toronto General Hospital, Toronto, Ontario, Canada.
  • Brass N; Division of Cardiology, QEII Health Sciences Centre, Halifax, Nova Scotia, Canada.
  • Chan AW; Division of Cardiology, CK Hui Heart Centre/Royal Alexandra Hospital, Edmonton, Alberta, Canada.
  • Colizza F; Division of Cardiology, Royal Columbian Hospital, New Westminster, British Columbia, Canada.
  • Constance C; Division of Cardiology, Centre Hospitalier Pierre-Boucher, Longueuil, Quebec, Canada.
  • Fam NP; Division of Cardiology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada.
  • Gobeil F; Division of Cardiology, St. Michael's Hospital, Montreal, Quebec, Canada.
  • Haghighat T; Division of Cardiology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
  • Hodge S; Division of Cardiology, CISSSO-Hull Hospital, Gatineau, Quebec, Canada.
  • Joyal D; Division of Cardiology, Kelowna General Hospital, Kelowna, British Columbia, Canada.
  • Kim HH; Division of Cardiology, Jewish General Hospital, Montreal, Quebec, Canada.
  • Lutchmedial S; Division of Cardiology, St-Mary's Regional Cardiac Care Centre, Kitchener-Waterloo, Ontario, Canada.
  • MacDougall A; Division of Cardiology, Saint John Regional Hospital, Saint John, New Brunswick, Canada.
  • Malik P; Division of Cardiology, Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada.
  • Miner S; Division of Cardiology, Kingston General Hospital, Kingston, Ontario, Canada.
  • Minhas K; Division of Cardiology, Southlake Regional Health Centre, Newmarket, Ontario, Canada.
  • Orvold J; Division of Cardiology, St. Boniface General Hospital, Winnipeg, Manitoba, Canada.
  • Palisaitis D; Division of Cardiology, Royal University Hospital, Saskatoon, Saskatchewan, Canada.
  • Parfrey B; Division of Cardiology, Sacred Heart Hospital, Montreal, Quebec, Canada.
  • Potvin JM; Division of Cardiology, Health Sciences Centre, St-John's, Newfoundland, Canada.
  • Puley G; Division of Cardiology, CHU de Québec, Quebec City, Quebec, Canada.
  • Radhakrishnan S; Division of Cardiology, Trillium Health Centre, Mississauga, Ontario, Canada.
  • Spaziano M; Division of Cardiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Tanguay JF; Division of Cardiology, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
  • Vijayaraghaban R; Division of Cardiology, Cardiology Institute of Montreal, Montreal, Quebec, Canada.
  • Webb JG; Division of Cardiology, Rouge Valley Centenary, Scarborough, Ontario, Canada.
  • Zimmermann RH; Division of Cardiology, St. Paul's Hospital, Vancouver, British Columbia, Canada.
  • Wood DA; Division of Cardiology, Regina General Hospital, Regina, Saskatchewan, Canada.
  • Brophy JM; Division of Cardiology, Vancouver General Hospital, Vancouver, British Columbia, Canada.
CJC Open ; 3(9): 1125-1131, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-1225176
ABSTRACT

BACKGROUND:

As a result of the COVID-19 pandemic first wave, reductions in ST-elevation myocardial infarction (STEMI) invasive care, ranging from 23% to 76%, have been reported from various countries. Whether this change had any impact on coronary angiography (CA) volume or on mechanical support device use for STEMI and post-STEMI mechanical complications in Canada is unknown.

METHODS:

We administered a Canada-wide survey to all cardiac catheterization laboratory directors, seeking the volume of CA use for STEMI performed during the period from March 1 2020 to May 31, 2020 (pandemic period), and during 2 control periods (March 1, 2019 to May 31, 2019 and March 1, 2018 to May 31, 2018). The number of left ventricular support devices used, as well as the number of ventricular septal defects and papillary muscle rupture cases diagnosed, was also recorded. We also assessed whether the number of COVID-19 cases recorded in each province was associated with STEMI-related CA volume.

RESULTS:

A total of 41 of 42 Canadian catheterization laboratories (98%) provided data. There was a modest but statistically significant 16% reduction (incidence rate ratio [IRR] 0.84; 95% confidence interval 0.80-0.87) in CA for STEMI during the first wave of the pandemic, compared to control periods. IRR was not associated with provincial COVID-19 caseload. We observed a 26% reduction (IRR 0.74; 95% confidence interval 0.61-0.89) in the use of intra-aortic balloon pump use for STEMI. Use of an Impella pump and mechanical complications from STEMI were exceedingly rare.

CONCLUSIONS:

We observed a modest 16% decrease in use of CA for STEMI during the pandemic first wave in Canada, lower than the level reported in other countries. Provincial COVID-19 caseload did not influence this reduction.

INTRODUCTION:

Après la première vague de la pandémie de COVID-19, de nombreux pays ont déclaré une réduction de 23 % à 76 % des soins invasifs de l'infarctus du myocarde avec élévation du segment ST (STEMI). On ignore si ce changement a entraîné des répercussions sur le volume d'angiographies coronariennes (AC) ou sur l'utilisation des dispositifs d'assistance mécanique lors de STEMI et des complications mécaniques post-STEMI au Canada. MÉTHODES Nous avons réalisé un sondage pancanadien auprès de tous les directeurs de laboratoire de cathétérisme cardiaque pour obtenir le volume d'utilisation des AC lors des STEMI réalisées durant la période du 1er mars 2020 au 31 mai 2020 (période de pandémie) et durant 2 périodes témoins (1er mars 2019 au 31 mai 2019 et 1er mars 2018 au 31 mai 2018). Le nombre de dispositifs d'assistance ventriculaire gauche utilisés et le nombre de cas de communications interventriculaires et de ruptures du muscle papillaire diagnostiqués ont également été enregistrés. Nous avons aussi évalué si le nombre de cas de COVID-19 enregistrés dans chaque province était associé au volume d'AC liées aux STEMI. RÉSULTATS Au total, 41 des 42 laboratoires canadiens de cathétérisme (98 %) ont fourni des données. Lors de la comparaison de la première vague de la pandémie aux périodes témoins, nous avons noté une réduction modeste, mais significative, sur le plan statistique de 16 % (ratio du taux d'incidence [RTI] 0,84; intervalle de confiance à 95 % 0,80-0,87) des AC lors de STEMI. Le RTI n'était pas associé au nombre provincial de cas de COVID-19. Nous avons observé une réduction de 26 % (RTI 0,74; intervalle de confiance à 95 % 0,61-0,89) de l'utilisation de pompes à ballonnet intra-aortique lors de STEMI. L'utilisation d'une pompe Impella et les complications mécaniques après les STEMI étaient extrêmement rares.

CONCLUSIONS:

Nous avons observé une diminution modeste de 16 % de l'utilisation des AC lors de STEMI durant la première vague de la pandémie au Canada, soit une diminution plus faible que ce que les autres pays ont signalé. Le nombre provincial de cas de COVID-19 n'a pas influencé cette réduction.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study Language: English Journal: CJC Open Year: 2021 Document Type: Article Affiliation country: J.cjco.2021.04.017

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study Language: English Journal: CJC Open Year: 2021 Document Type: Article Affiliation country: J.cjco.2021.04.017